- CA$39.97m
- CA$38.84m
- CA$28.86m
Brief: Medicure FDA approves new Aggrastat product format
Brief: Medicure reports Q2 earnings per share $0.03
Brief: Medicure receives response letter from FDA on Aggrastat SNDA for new indication
Brief: Medicure Inc qtrly earnings per share $0.01
Brief: Medicure says COO Dawson Reimer will leave the company
Brief: Medicure reports qtrly rev of $9.5 million
Brief: Medicure announces preliminary revenue for fiscal 2015
Brief: Medicure says has initiated development of high-value cardiovascular generic drug